Prolongation of Progesterone Supplementation in Antagonist Cycles and Pregnancy Outcomes

Phase 1

Completed

• Conditions: Infertility
• Interventions: Drug: progesterone

• Registration Number: NCT01147770
• Lead Sponsor: Universitair Ziekenhuis Brussel

Brief Summary

The objective of this study is to evaluate the effect of the prolongation of luteal support on the ongoing pregnancy rate (beyond 12 weeks of gestation )in recFSH/GnRH antagonist cycles.

Detailed Description

Not available

Study Timeline

• Study Start: 2008-09
• Primary Completion: 2010-01
• Study Completion: 2010-06
• Study First Submitted: 2010-06-17
• Study First Submitted QC: 2010-06-18
• Study First Posted: 2010-06-22
• Status Verified: 2013-07
• Last Update Submitted: 2013-07-01
• Last Update Posted: 2013-07-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 200

Inclusion Criteria

• Age equal or less than 39
• Body mass index between 18-29 kg/m2
• Presence of both ovaries
• Basal hormonal values on day 2 of the cycle
• Embryotransfer day3 or day5
• 1 to 3 cycles

Exclusion Criteria

• Endometriosis stage 3
• Polycystic ovarian syndrome
• Frozen or testicular sperm

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
stop progesterone	progesterone	-

Primary Outcome Measures

Name	Time	Method
ongoing pregnancy rate	up to 2 years